Monthly Prescribing Reference

Incruse Ellipta

Umeclidinium 62.5mcg; per inhalation; dry pwd for oral inhalation; contains lactose. Incruse Ellipta should be stored at room temperature between 68°-77° F (20°-25° C); excursions permitted from ...
FiercePharma

GSK receives EU marketing authorisation for Incruse® (umeclidinium) for the treatment of COPD

GlaxoSmithKline plc (LSE/NYSE: GSK) announced today that the European Commission has granted marketing authorisation for Incruse® (umeclidinium) as a once-daily, maintenance bronchodilator treatment ...
Monthly Prescribing Reference

Incruse Ellipta Inhaler Approved for COPD

Incruse Ellipta Inhaler Approved for COPD GlaxoSmithKline announced that the FDA has approved Incruse Ellipta (umeclidinium) inhaler for the long-term, once-daily, maintenance treatment of airflow ...
FiercePharma

GSK and Theravance announce positive data from two studies evaluating the efficacy and safety of Incruse™ Ellipta® when added to Relvar®/Breo® Ellipta® in patients with COPD

GSK and Theravance announce positive data from two studies evaluating the efficacy and safety of Incruse™ Ellipta® when added to Relvar®/Breo® Ellipta® in patients with COPD GlaxoSmithKline plc ...
Fox Business

FDA OKs Glaxo's inhaler, first one to combine 3 medicines

The Food and Drug Administration has approved the first inhaler combining three medicines to ease breathing in patients with emphysema or chronic bronchitis. The FDA late Monday approved sales of ...
Athens Banner-Herald

FDA OKs Glaxo's inhaler, first one to combine 3 medicines

TRENTON, N.J. | The Food and Drug Administration has approved the first inhaler combining three medicines to ease breathing in patients with emphysema or chronic bronchitis. The FDA late Monday ...
Washington Times

FDA OKs Glaxo’s inhaler, first one to combine 3 medicines

TRENTON, N.J. (AP) - The Food and Drug Administration has approved the first inhaler combining three medicines to ease breathing in patients with emphysema or chronic bronchitis. The FDA late Monday ...
Yahoo

FDA OKs Glaxo's inhaler, first one to combine 3 medicines

This photo provided by GlaxoSmithKline PLC shows the company's Trelegy Ellipta inhaler. Late Monday, Sept. 18, 2017, the Food and Drug Administration approved the product, which is the first inhaler ...
WRAL TechWire

FDA OKs Glaxo’s inhaler which is first one to combine 3 medicines

The Food and Drug Administration has approved the first inhaler combining three medicines to ease breathing in patients with emphysema or chronic bronchitis. The FDA earlier this week approved sales ...
Seattle Times

FDA OKs Glaxo’s inhaler, first one to combine 3 medicines

TRENTON, N.J. (AP) — The Food and Drug Administration has approved the first inhaler combining three medicines to ease breathing in patients with emphysema or chronic bronchitis. The FDA late Monday ...